Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-90 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0667 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0655 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0662 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0654 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-077 |
filingDate |
2021-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2022-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2022-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-113403267-B |
titleOfInvention |
Biological ink for treating bone injury and preparation method thereof |
abstract |
The present invention provides a bio-ink comprising gelatin or a gelatin derivative, hyaluronic acid or a hyaluronic acid derivative, an acellular matrix, and exosomes, a method of manufacturing the same, and a bio-scaffold manufactured by 3D printing using the bio-ink. |
priorityDate |
2021-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |